Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Open accessThe DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A growing number of observational and epidemiological studies have suggested that mental illness, in particular mood disorders, is associated with reduced dietary intake and/or cellular abundance of omega-3 polyunsaturated fatty acids (PUFA). This has prompted researchers to test the efficacy of omega-3 PUFA in a range of different psychiatric disorders. We have critically reviewed the double blind placebo controlled clinical trials published prior to April 2007 to determine whether omega-3 PUFA are likely to be efficacious in these disorders. RESULTS: Most trials involved a small number of participants but were largely well designed. Omega-3 PUFA were well tolerated by both children and adults with mild gastrointestinal effects being the only consistently reported adverse event. For schizophrenia and borderline personality disorder we found little evidence of a robust clinically relevant effect. In the case of attention deficit hyperactivity disorder and related disorders, most trials showed at most small benefits over placebo. A limited meta-analysis of these trials suggested that benefits of omega-3 PUFA supplementation may be greater in a classroom setting than at home. Some evidence indicates that omega-3 PUFA may reduce symptoms of anxiety although the data is preliminary and inconclusive. The most convincing evidence for beneficial effects of omega-3 PUFA is to be found in mood disorders. A meta-analysis of trials involving patients with major depressive disorder and bipolar disorder provided evidence that omega-3 PUFA supplementation reduces symptoms of depression. Furthermore, meta-regression analysis suggests that supplementation with eicosapentaenoic acid may be more beneficial in mood disorders than with docosahexaenoic acid, although several confounding factors prevented a definitive conclusion being made regarding which species of omega-3 PUFA is most beneficial. The mechanisms underlying the apparent efficacy of omega-3 PUFA in mood disorders compared to schizophrenia are discussed as is a rational for the possibly greater efficacy of EPA compared to DHA. CONCLUSION: While it is not currently possible to recommend omega-3 PUFA as either a mono- or adjunctive-therapy in any mental illness, the available evidence is strong enough to justify continued study, especially with regard to attentional, anxiety and mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Standardized mean differences in depressive symptoms in omega-3 PUFA-treated compared to placebo-treated subjects with major depressive disorder or bipolar disorder. SMD are the standardized mean differences (scaled to standard deviations) in the change-from-baseline scores in the placebo and treatment groups, along with 95% confidence intervals. A summary of each study's characteristics can be found in Table 4. All studies rated patients using the HDRS, except that conducted by Llorente and colleagues [73], which was therefore excluded from the analysis. I-squared is the proportion of variance attributable to the heterogeneity between studies, and the p-value is for Cohen's Q, a test of the statistical significance of that heterogeneity. The overall estimate is the inverse-variance-weighted average of the studies based on a random effects model.](https://figures.cochat.ai/paper-figures/4644b16628814a19bd814c7575501270/omega-3-fatty-acids-as-treatments-for-mental-illness-which-disorder-and-which-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Finally, there is no consistent evidence from randomised control trials for the use of food supplements, such as omega-3 fatty acids ADHD [305].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [305]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
(1976) · Medical Entomology and Zoology · Cited by 8,899
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,381
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
(1983) · Medical Entomology and Zoology · Cited by 4,251
Department of Health, Education, and Welfare
Cooper, T. (1976) · Military Medicine · doi:10.1093/milmed/141.8.521 · Cited by 3,993
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,412
The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency
Kim, S. W., Dysken, M. W., Pheley, A. M., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,359
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162
(1985) · PubMed · Cited by 1,427
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931
The inventory for depressive symptomatology (IDS): Preliminary findings
John Rush, A., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J., & Burns, C. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90060-0 · Cited by 918
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
(2008) · Cited by 889
Mueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Increasing Rates of Depression
Klerman, G. L. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420150079041 · Cited by 779
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Nemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
Peet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 614
Omega-3 fatty acids in major depressive disorder
Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00032-4 · Cited by 596
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000057393.97337.ae · Cited by 596
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Chen, Y.-W., & Dilsaver, S. C. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00295-2 · Cited by 505
Emken, E. A., Adlof, R. O., & Gulley, R. M. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00054-9 · Cited by 488
Clinicians' Judgments of Mental Health: A Proposed Scale
LUBORSKY, L. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01720060019002 · Cited by 459
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 455
Omega-3 fatty acids and monoamine neurotransmission
Chalon, S. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.005 · Cited by 448
Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder
Stevens, L., Zentall, S., Deck, J., Abate, M., Watkins, B., Lipp, Sr., & Burgess, Jr. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.4.761 · Cited by 445
Richardson, A. J., & Montgomery, P. (2005) · Pediatrics · doi:10.1542/peds.2004-2164 · Cited by 438
A Depression Rating Scale for Children
Poznanski, E. O., Cook, S. C., & Carroll, B. J. (1979) · Pediatrics · doi:10.1542/peds.64.4.442 · Cited by 392
Marangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F. S., & Puryear, L. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.996 · Cited by 380
Richardson, A. J., & Puri, B. K. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00254-8 · Cited by 378
Voigt, R. G., Llorente, A. M., Jensen, C. L., Fraley, J. K., Berretta, M. C., & Heird, W. C. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116050 · Cited by 365
Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (1996) · Medical Entomology and Zoology · Cited by 363
Omega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study
Nemets, H., Nemets, B., Apter, A., Bracha, Z., & Belmaker, R. H. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1098 · Cited by 358
Horrocks, L. A., & Farooqui, A. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.011 · Cited by 356
Amminger, G. P., Berger, G. E., Schäfer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.007 · Cited by 355
Zanarini, M. C., & Frankenburg, F. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.167 · Cited by 352
Serhan, C. N., Arita, M., Hong, S., & Gotlinger, K. (2004) · Lipids · doi:10.1007/s11745-004-1339-7 · Cited by 349
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors
Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S. S., Eugene Arnold, L., & Burgess, J. R. (2003) · Lipids · doi:10.1007/s11745-006-1155-0 · Cited by 337
Peet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329
Peet, M., & Horrobin, D. F. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00048-6 · Cited by 329
Fenton, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R., & Knable, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2071 · Cited by 323
Frangou, S., Lewis, M., & McCrone, P. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.46 · Cited by 309
Emsley, R., Myburgh, C., Oosthuizen, P., & van Rensburg, S. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1596 · Cited by 306
Hirayama, S., Hamazaki, T., & Terasawa, K. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601830 · Cited by 288
Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., & Lodi, L. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01570.x · Cited by 284
Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism
Piomelli, D., Pilon, C., Giros, B., Sokolofff, P., Martres, M.-P., & Schwartz, J.-C. (1991) · Nature · doi:10.1038/353164a0 · Cited by 258
Omega-3 fatty acids from fish oils and cardiovascular disease
Holub, D. J., & Holub, B. J. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041863.11248.8d · Cited by 258
Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children
Mitchell, E. A., Aman, M. G., Turbott, S. H., & Manku, M. (1987) · Clinical Pediatrics · doi:10.1177/000992288702600805 · Cited by 246
Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat
Kodas, E., Galineau, L., Bodard, S., Vancassel, S., Guilloteau, D., Besnard, J., & Chalon, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02401.x · Cited by 244
Keck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234
Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder
Burgess, J. R., Stevens, L., Zhang, W., & Peck, L. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.327s · Cited by 222
COX-2 Inhibitory Effects of Naturally Occurring and Modified Fatty Acids
Ringbom, T., Huss, U., Stenholm, Å., Flock, S., Skattebøl, L., Perera, P., & Bohlin, L. (2001) · Journal of Natural Products · doi:10.1021/np000620d · Cited by 218
Bipolar depression: phenomenological overview and clinical characteristics
Mitchell, P. B., & Malhi, G. S. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00137.x · Cited by 210
(2006) · PubMed · Cited by 207
Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
Silvers, K. M., Woolley, C. C., Hamilton, F. C., Watts, P. M., & Watson, R. A. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.11.004 · Cited by 207
Omega-3 fatty acids and cardiovascular disease
von Schacky, C. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3280127af0 · Cited by 207
De Vriese, S. R., Christophe, A. B., & Maes, M. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.02.001 · Cited by 200
Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depression
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Brumbach, B. H., Watchman, M., & Gelenberg, A. J. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00660.x · Cited by 199
Essential fatty acids and phospholipase A2 in autistic spectrum disorders
Bell, J. G., MacKinlay, E. E., Dick, J. R., MacDonald, D. J., Boyle, R. M., & Glen, A. C. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.03.008 · Cited by 199
Bruss, G. S., Gruenberg, A. M., Goldstein, R. D., & Barber, J. P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90110-4 · Cited by 193
Richardson, A. J., & Ross, M. A. (2000) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2000.0184 · Cited by 193
Llorente, A. M., Jensen, C. L., Voigt, R. G., Fraley, J. K., Berretta, M. C., & Heird, W. C. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.275 · Cited by 189
Risperidone versus typical antipsychotic medication for schizophrenia
Hunter, R., Kennedy, E., Song, F., Gadon, L., & Irving, C. B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000440 · Cited by 183
Developmental Coordination Disorder
Phd, D., & Wilson, B. (2001) · Physical & Occupational Therapy In Pediatrics · doi:10.1300/j006v20n02_02 · Cited by 171
Zimmer, L., Delpal, S., Guilloteau, D., Aı̈oun, J., Durand, G., & Chalon, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00950-2 · Cited by 167
Increasing rates of depression
Klerman, G. L. (1989) · JAMA · doi:10.1001/jama.261.15.2229 · Cited by 166
Carlezon, W. A., Mague, S. D., Parow, A. M., Stoll, A. L., Cohen, B. M., & Renshaw, P. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.038 · Cited by 162
Berge, R. K., Madsen, L., Vaagenes, H., Tronstad, K. J., Göttlicher, M., & Rustan, A. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430191 · Cited by 148
Kodas, E., Vancassel, S., Lejeune, B., Guilloteau, D., & Chalon, S. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200132-jlr200 · Cited by 146
The effects of essential fatty acid supplementation by efamol in hyperactive children
Aman, M. G., Mitchell, E. A., & Turbott, S. H. (1987) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00916467 · Cited by 143
Bekaroǧlu, M., Asian, Y., Gedik, Y., Deǧer, O., Mocan, H., Erduran, E., & Karahan, C. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01395.x · Cited by 142
The validity of autistic spectrum disorders: A literature review
Szatmári, P. (1992) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01046329 · Cited by 142
Levant, B., Radel, J. D., & Carlson, S. E. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.029 · Cited by 137
CLINICAL USE OF RATING SCALES IN DIAGNOSIS AND TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Conners, C. K. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70159-0 · Cited by 135
Polyunsaturated fatty acid supplementation for schizophrenia
Irving, C. B., Mumby-Croft, R., & Joy, L. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001257.pub2 · Cited by 135
Depressive Disorders in Childhood and Adolescence: An Overview
Zalsman, G., Brent, D. A., & Weersing, V. R. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2006.05.002 · Cited by 135
Vial, D., & Piomelli, D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062765.x · Cited by 132
Joshi, K. S., Lad, S. S., Kale, M., Patwardhan, B., Mahadik, S. P., Patni, B., Chaudhary, A., Bhave, S. A., & Pandit, A. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.10.001 · Cited by 130
Zimmer, L., Hembert, S., Durand, G., Breton, P., Guilloteau, D., Besnard, J., & Chalon, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00938-5 · Cited by 124
Green, P., Hermesh, H., Monselise, A., Marom, S., Presburger, G., & Weizman, A. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.07.005 · Cited by 123
The potential role of fatty acids in attention-deficit/hyperactivity disorder
Richardson, A. J., & Puri, B. K. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0196 · Cited by 123
Arnold, L. E., Kleykamp, D., Votolato, N. A., Taylor, W. A., Kontras, S. B., & Tobin, K. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90167-4 · Cited by 118
(2004) · PubMed · Cited by 117
Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Sawazaki, S., Tanouchi, M., Watanabe, S., Hamazaki, T., TERASAWA, K., & Yazawa, K. (2005) · Nutrition · doi:10.1016/j.nut.2004.07.020 · Cited by 113
Eicosanoids in the central nervous system
Leslie, J. B., & Watkins, W. D. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.63.5.0659 · Cited by 105
Mixture of essential fatty acids lowers test anxiety
Yehuda, S., Rabinovitz, S., & Mostofsky, D. I. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500445795 · Cited by 103
Philbrick, D.-J., Mahadevappa, V. G., ACKMAN, R. G., & Holub, B. J. (1987) · Journal of Nutrition · doi:10.1093/jn/117.10.1663 · Cited by 102
A placebo-controlled cross-over trial of adjunctive EPA in OCD
Fux, M., Benjamin, J., & Nemets, B. (2004) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00077-3 · Cited by 99
PET and SPECT Imaging in Psychiatric Disorders
Zipursky, R. B., Meyer, J. H., & Verhoeff, N. P. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200303 · Cited by 93
Marangell, L. B., Martinez, J. M., Zboyan, H. A., Chong., H., & Puryear, L. J. (2004) · Depression and Anxiety · doi:10.1002/da.10148 · Cited by 92
Horrobin, D. F., Jenkins, K., Bennett, C. N., & Christie, W. W. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0338 · Cited by 89
Ross, B. M., McKenzie, I., Glen, I., & Bennett, C. P. W. (2003) · Nutritional Neuroscience · doi:10.1080/10284150310001612203 · Cited by 86
Self-citationOmega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study
Nemets, H. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.6.1098 · Cited by 72
Neuroscientific basis and practical applications
Stahl, S. M., Muntner, N., & Grady, M. M. (2008) · Cambridge University Press eBooks · Cited by 67
Innis, S. M., Rioux, F. M., Auestad, N., & ACKMAN, R. G. (1995) · Journal of Nutrition · doi:10.1093/jn/125.9.2286 · Cited by 67
Covault, J., Pettinati, H., Moak, D., Mueller, T., & Kranzler, H. R. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20156 · Cited by 67
Ross, B. M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.07.054 · Cited by 60
Self-citationThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90266-2 · Cited by 60
n-3 Polyunsaturated Fatty Acids Decrease Anxiety Feelings in a Population of Substance Abusers
Buydens-Branchey, L., & Branchey, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000246214.49271.f1 · Cited by 57
Ratey, J. J., & Gutheil, C. M. (1991) · PubMed · Cited by 53
Characterization of Lysophospholipid Metabolizing Enzymes in Human Brain
Ross, B. M., & Kish, S. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051839.x · Cited by 51
Self-citationADHD and Drug Therapy: is it Still a Valid Treatment?
Doggett, A. M. (2004) · Journal of Child Health Care · doi:10.1177/1367493504041856 · Cited by 51
Sergeeva, M., Strokin, M., & Reiser, G. (2005) · Reproduction Nutrition Development · doi:10.1051/rnd:2005050 · Cited by 50
Teale, M. C. (2006) · Medical Entomology and Zoology · Cited by 46
Omega-3 fatty acids and cardiovascular disease
von Schacky, C. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200403000-00005 · Cited by 42
Hamazaki, T., & Hirayama, S. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601888 · Cited by 42
Hawkes, J. S., James, M. J., & Cleland, L. G. (1991) · Prostaglandins · doi:10.1016/0090-6980(91)90084-s · Cited by 38
Omega-3 Fatty Acid for Schizophrenia
Horrobin, D. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.188 · Cited by 37
Evans, K. L. J., Cropper, J. D., Berg, K. A., & Clarke, W. P. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29629-4 · Cited by 34
Omega-3 fatty acids in bipolar disorder: Clinical and research considerations
Marangell, L. B., Suppes, T. M., Ketter, T. A., Dennehy, E. B., Zboyan, H. A., Kertz, B. L., Nierenberg, A. A., Calabrese, J. R., Wisniewski, S. R., & Sachs, G. S. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.008 · Cited by 32
Obajimi, O., Black, K., MacDonald, D. J., Boyle, R. M., Glen, I., & Ross, B. M. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.024 · Cited by 24
Self-citationDevelopmental Coordination Disorder: What Is It?
Missiuna, C. (2013) · Routledge eBooks · doi:10.4324/9780203048481-3 · Cited by 24
The Use of Selective Serotonin Reuptake Inhibitors in Pregnancy
Wen, S. W., & WALKER, M. C. (2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30155-4 · Cited by 22
Colquhoun, A., Ramos, K. L., & Schumacher, R. I. (2001) · Cell Biochemistry and Function · doi:10.1002/cbf.902 · Cited by 18
Normative data for the tactual performance test
Cauthen, N. R. (1978) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197804)34:2<426::aid-jclp2270340236>3.0.co;2-x · Cited by 15
Dr. Fenton and Colleagues Reply
Fenton, W. S., Dickerson, F., Boronow, J. J., Hibbeln, J. R., & Knable, M. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.189 · Cited by 4
Cited by
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
Depression as a disease of modernity: explanations for increasing prevalence
Hidaka, B. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.036 · Cited by 769
Patrick, R. P., & Ames, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-268342 · Cited by 491
Production of omega-3 polyunsaturated fatty acid concentrates: A review
Rubio-Rodríguez, N., Beltrán, S., Jaime, I., de Diego, S. M., Sanz, M. T., & Carballido, J. R. (2010) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.10.006 · Cited by 490
Metadata
- Authors
- Ross, B. M., Seguin, J., & Sieswerda, L. E.
- Affiliations
- Lakehead University (CA)
- Thunder Bay District Health Unit (CA)
- Corresponding author
- Ross, Brian M
- Venue
- Lipids in Health and Disease
- Published
- 2007
- Volume
- 6
- Issue
- 1
- Pages
- 21
- ISSN
- 1476-511X (ISSN-L)
- PMC
- PMC2071911
- OpenAlex
- W2117752152
- Cited by
- 275
- References
- 132
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 12 · 2020: 4 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 22 · 2015: 19 · 2014: 22 · 2013: 19 · 2012: 22
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Lipids in Health and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Lakehead University
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- omega-3 polyunsaturated fatty acids, dietary supplementation, mental illness, mood disorders, major depressive disorder, bipolar disorder, schizophrenia, borderline personality disorder, attention deficit hyperactivity disorder, anxiety, eicosapentaenoic acid, docosahexaenoic acid, meta-regression
- MeSH terms
- Animals, Mental Disorders, Humans, Personality, Meta-Analysis as Topic, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.